Evidence map›Paper›PMID 34523822›Full record

ArticleJournal of cachexia, sarcopenia and muscle2021

Inflammatory markers are associated with quality of life, physical activity, and gait speed but not sarcopenia in aged men (40-79 years).

Jolan Dupont, Leen Antonio, Lenore Dedeyne, Terence W O'Neill, Dirk Vanderschueren, Giulia Rastrelli, Mario Maggi, György Bártfai, Felipe F Casanueva, Aleksander Giwercman and 7 more

Open access · goldAbstract read
In one paragraph

Article in Journal of cachexia, sarcopenia and muscle, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 3 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 3 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Factors Associated with Low Albumin in Community-Dwelling Older Adults Aged 75 Years and Above.International journal of environmental research and public health · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 11 institutions in 9 countries.

Jolan DupontGeriatrics and Gerontology, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.ORCID 0000-0001-5336-2791
Leen AntonioClinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.ORCID 0000-0002-1079-2860
Lenore DedeyneGeriatrics and Gerontology, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.ORCID 0000-0001-6109-5216
Terence W O'NeillCentre for Epidemiology Versus Arthritis, The University of Manchester, NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, UK.ORCID 0000-0002-8896-4677
Dirk VanderschuerenClinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.ORCID 0000-0003-1395-0104
Giulia RastrelliAndrology, Women's Endocrinology and Gender Incongruence Unit, Mario Serio 'Department of Experimental and Clinical Biomedical Sciences', University of Florence, Florence, Italy.ORCID 0000-0002-6164-4278
Mario MaggiEndocrinology Unit, Mario Serio 'Department of Experimental and Clinical Biomedical Sciences', University of Florence, Florence, Italy.ORCID 0000-0003-3267-4221
György BártfaiDepartment of Obstetrics, Gynaecology and Andrology, Albert Szent-Györgyi Medical University, Szeged, Hungary.
Felipe F CasanuevaDepartment of Medicine, Santiago de Compostela University, Complejo Hospitalario Universitario de Santiago (CHUS), Santiago, Spain.ORCID 0000-0002-9052-8161
Aleksander GiwercmanDepartment of Translational Medicine, Lund University, Malmö, Sweden.
Jolanta Słowikowska-HilczerDepartment of Andrology and Reproductive Endocrinology, Medical University of Lodz, Łódź, Poland.ORCID 0000-0003-3105-1786
Margus PunabAndrology Unit, United Laboratories of Tartu University Clinics, Tartu, Estonia.ORCID 0000-0001-9601-6311
Ilpo T HuhtaniemiDepartment of Metabolism, Digestion and Reproduction, Institute of Reproductive and Developmental Biology, Imperial College London, London, UK.ORCID 0000-0001-9092-7886
Frederick C W WuDepartment of Endocrinology, Manchester Royal Infirmary, The University of Manchester, Manchester, UK.ORCID 0000-0002-7005-4798
Jos TournoyGeriatrics and Gerontology, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.ORCID 0000-0002-0265-9154
Katrien KoppoExercise Physiology Research Group, Department of Movement Sciences, KU Leuven, Leuven, Belgium.ORCID 0000-0002-6022-1097
Evelien GielenGeriatrics and Gerontology, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.ORCID 0000-0002-8985-1201
KU Leuven · BEUniversitair Ziekenhuis Leuven · BEUniversity of Florence · ITDepartment of Public Health · USInstituto de Salud Carlos III · ESLund University · SEManchester Royal Infirmary · GBManchester University NHS Foundation Trust · GBMedical University of Lodz · PLTartu University Hospital · EEUniversity of Turku · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAge-related chronic low-grade inflammation (inflammaging) is one of the proposed mechanisms behind sarcopenia. However, findings regarding inflammatory markers in sarcopenic older adults are conflicting. This study aimed to determine the association between inflammatory markers, prevalent as well as incident sarcopenia, sarcopenia-defining parameters, quality of life (QoL), and physical activity in middle-aged and older men.

methodsMen aged 40-79 years (mean 59.66 ± 11.00y) were recruited from population registers in eight European centres for participation in the European Male Aging study (EMAS). Subjects were assessed at baseline (2003-2005) and again after a median follow-up of 4.29 years. In 2577 participants, associations between baseline inflammatory markers [high-sensitive C-reactive protein (hs-CRP), white blood cell count (WBC), albumin] and baseline physical activity (PASE) and QoL (SF-36) were analysed. In the Leuven and Manchester cohort (n = 447), data were available on muscle mass (whole-body dual X-ray absorptiometry) and strength. In this subgroup, cross-sectional associations between baseline inflammatory markers and sarcopenia-defining parameters (handgrip strength, chair stand test, appendicular lean mass, and gait speed) and prevalent sarcopenia were examined. In a further subgroup (n = 277), associations with knee extensor strength were explored. Longitudinally, predictive value of baseline inflammation on functional decline, physical activity, QoL, and incident sarcopenia was examined. Subgroup analyses were performed in subgroups with chronic inflammation and stratified by age. Linear and logistic regressions were used, adjusted for age, body mass index, centre, and smoking.

resultsAt baseline, hs-CRP and WBC were negatively associated with PASE score (hs-CRP: β = -7.920, P < 0.001; and WBC: β = -4.552, P < 0.001) and the physical component score of SF-36 (hs-CRP: β = -1.025, P < 0.001; and WBC: β = -0.364, P < 0.001). Baseline WBC levels were negatively associated with gait speed (β = -0.013; P = 0.025), quadriceps isometric 90° (β = -5.983; P = 0.035) and isokinetic 60°/s peak torque/body weight (β = -5.532; P = 0.027). The prevalence of sarcopenia at baseline was 18.1% (n = 81). Of those without sarcopenia at baseline, 64 (18.6%) satisfied criteria for sarcopenia at follow-up. There were no significant associations between baseline inflammatory markers and either prevalent or incident sarcopenia, or change in level of sarcopenia-defining parameters between baseline and follow-up.

conclusionsIn middle-aged and older men, hs-CRP and WBC were negatively associated with QoL and PASE scores, while WBC was negatively associated with gait speed and knee strength. Associations with hs-CRP remained significant in all ages, whereas WBC levels were only associated with PASE, gait speed and knee strength in older adults (60-79 years). Baseline inflammatory markers (hs-CRP, WBC and albumin) did not predict functional decline, decline in physical activity, decreased QoL or incident sarcopenia.

Indexed as

Quality of LifeSarcopeniaAgedBody Mass IndexCross-Sectional StudiesExerciseHand StrengthHumansMaleMiddle AgedWalking SpeedAgeingInflammagingInflammationMuscle strengthOlder adultSarcopenia

Identifiers

PMID34523822
PMCPMC8718046
OpenAlexW3200612034

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.